Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SurgePays (SURG) Liabilities and Shareholders Equity (2016 - 2025)

SurgePays has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $8.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 64.48% year-over-year to $8.5 million; the TTM value through Dec 2025 reached $53.9 million, down 71.85%, while the annual FY2025 figure was $8.5 million, 64.48% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $8.5 million at SurgePays, down from $14.5 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $69.6 million in Q1 2024 and troughed at $7.4 million in Q2 2021.
  • A 5-year average of $28.5 million and a median of $26.7 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 299.3% in 2022 and later plummeted 77.49% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $19.5 million in 2021, then surged by 74.38% to $34.0 million in 2022, then grew by 23.3% to $41.9 million in 2023, then plummeted by 42.81% to $24.0 million in 2024, then tumbled by 64.48% to $8.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for SURG at $8.5 million in Q4 2025, $14.5 million in Q3 2025, and $15.2 million in Q2 2025.